Standout Papers

Pooled Analysis of Long-Term Survival Data Fr... 2003 2026 2010 2018 1.5k
  1. Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma (2015)
    Dirk Schadendorf, F. Stephen Hodi et al. Journal of Clinical Oncology
  2. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours (2003)
    David M. Berman, Sunil Karhadkar et al. Nature
  3. Tissue repair and stem cell renewal in carcinogenesis (2004)
    Philip A. Beachy, Sunil Karhadkar et al. Nature
  4. Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer (2003)
    D. Neil Watkins, David M. Berman et al. Nature
  5. A stem cell–like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing (2007)
    Joyce E. Ohm, Kelly M. McGarvey et al. Nature Genetics
  6. Hedgehog signalling in prostate regeneration, neoplasia and metastasis (2004)
    Sunil Karhadkar, G. Steven Bova et al. Nature
  7. Structure of RGS4 Bound to AlF4−-Activated Giα1: Stabilization of the Transition State for GTP Hydrolysis (1997)
    J.J.G. Tesmer, David M. Berman et al. Cell
  8. GAIP and RGS4 Are GTPase-Activating Proteins for the Gi Subfamily of G Protein α Subunits (1996)
    David M. Berman, Thomas M. Wilkie et al. Cell
  9. Medulloblastoma Growth Inhibition by Hedgehog Pathway Blockade (2002)
    David M. Berman, Sunil Karhadkar et al. Science
  10. An immune-active tumor microenvironment favors clinical response to ipilimumab (2011)
    Rui‐Ru Ji, Scott D. Chasalow et al. Cancer Immunology Immunotherapy
  11. Deletion of steroid 5α-reductase 2 gene in male pseudohermaphroditism (1991)
    Stefan Andersson, David M. Berman et al. Nature
  12. Evolving synergistic combinations of targeted immunotherapies to combat cancer (2015)
    Ignacio Melero, David M. Berman et al. Nature reviews. Cancer
  13. Clinical implications of PTEN loss in prostate cancer (2018)
    Tamara Jamaspishvili, David M. Berman et al. Nature Reviews Urology
  14. Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma (2013)
    Jedd D. Wolchok, F. Stephen Hodi et al. Annals of the New York Academy of Sciences

Immediate Impact

23 by Nobel laureates 30 from Science/Nature 103 standout
Sub-graph 1 of 16

Citing Papers

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma
2021 Standout
2 intermediate papers

Works of David M. Berman being referenced

Optimizing management of advanced urothelial carcinoma: A review of emerging therapies and biomarker-driven patient selection
2020
Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
2015 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
David M. Berman 10835 7542 1918 3483 254 19.4k
David Piwnica‐Worms 9026 5675 1175 3270 279 19.2k
James D. Griffin 12646 7357 1396 5262 352 29.3k
Bruce J. Aronow 12872 3851 2872 3798 322 22.9k
David W. Andrews 10060 3621 1482 1823 339 20.3k
Lucio Miele 10617 5254 758 2880 274 17.9k
Malcolm A.S. Moore 13031 7483 1951 7298 336 28.2k
Agnès Viale 11919 5329 1335 1951 138 20.3k
C. Patrick Reynolds 12521 4945 1037 2530 336 21.4k
Alan R. Clarke 12091 6931 1261 2340 228 18.4k
Antony W. Burgess 9027 5277 580 2781 257 16.4k

All Works

Loading papers...

Rankless by CCL
2026